Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$1.36 - $2.26 $1,538 - $2,556
-1,131 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.87 - $1.45 $983 - $1,639
1,131 New
1,131 $2,000
Q2 2019

Aug 14, 2019

SELL
$0.67 - $0.91 $757 - $1,029
-1,131 Closed
0 $0
Q4 2018

May 23, 2019

BUY
$0.85 - $2.1 $961 - $2,375
1,131 New
1,131 $1,000

Others Institutions Holding SNGX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About SOLIGENIX, INC.


  • Ticker SNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,105,200
  • Market Cap $143M
  • Description
  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...
More about SNGX
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.